Studies on the involvement of the dopaminergic system in the 5-HT2 agonist (DOI)-induced premature responding in a five-choice serial reaction time task

Aghajanian, 2000, Serotonin model of schizophrenia, Brain Res. Rev., 31, 302, 10.1016/S0165-0173(99)00046-6 Andersen, 1988, Comparison of pharmacological characteristics of [3H]raclopride and [3H]SCH23390 binding to dopamine receptors in vivo in mouse brain, Eur. J. Pharmacol., 146, 113, 10.1016/0014-2999(88)90492-X Andrews, 1978, The effects of 5-hydroxytryptophan and 5-hydroxytryptamine on dopamine synthesis and release in rat brain striatal synaptosomes, J. Neurochem., 30, 465, 10.1111/j.1471-4159.1978.tb06551.x Arborelius, 1993, The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons, Naunyn Schmiedebergs Arch. Pharmacol., 347, 353, 10.1007/BF00165384 Barnes, 1999, A review of central 5-HT receptors and their function, Neuropharmacology, 38, 1083, 10.1016/S0028-3908(99)00010-6 Baunez, 1997, Bilateral lesions of subthalamic nucleus induce multiple deficits in an attentional task in rats, Eur. J. Neurosci., 9, 2086, 10.1111/j.1460-9568.1997.tb01376.x Bizot, 1996, Impulsivity as a confounding factor in certain animal tests of cognitive function, Cogn. Brain Res., 3, 243, 10.1016/0926-6410(96)00010-9 Bischoff, 1986, The D-1 dopamine receptor antagonist SCH23390 also interacts potently with brain serotonin (5-HT2) receptors, Eur. J. Pharmacol., 129, 367, 10.1016/0014-2999(86)90449-8 Blandina, 1989, Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in the rat striatum, J. Pharmacol. Exp. Ther., 251, 803 Bobillier, P.; Seguin, S.; Petitjean, F.; Salvert, D.; Touret, M.; Jouvet, M. The raphe nuclei of the cat brain stem: A topographical atlas of their efferent projections as revealed by autoradiography. Brain Res. 113:449–486; 1976. Carli, 2000, The 5-HT1A receptor agonist 8-OH-DPAT reduces rats’ accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task, Psychopharmacology (Berl.), 149, 259, 10.1007/s002139900368 Carlsson, A. Interaction between dopaminergic and serotonergic systems. Clin. Neuropharmacol. 15(Suppl. 1):616A–617A; 1992. Christensen, A. V.; Arnt, J.; Hyttel, J.; Larsen, J. J.; Svenden, O. Behavioral correlates to the dopamine D-1 and D-2 antagonists. Pol. J. Pharmacol. Pharm. 36:249–232; 1984. Cole, 1987, Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task, Psychopharmacology (Berl.), 91, 458, 10.1007/BF00216011 Cole, 1989, Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats, Behav. Brain Res., 33, 165, 10.1016/S0166-4328(89)80048-8 Devaud, 1992, Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin2 receptor antagonist, ritanserin, J. Neurochem., 59, 1459, 10.1111/j.1471-4159.1992.tb08461.x Devaud, 1991, Effects of the 5-HT2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbens, Eur. J. Pharmacol., 192, 427, 10.1016/0014-2999(91)90235-I Ennis, 1981, Characterization of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum, J. Neurochem., 36, 1515, 10.1111/j.1471-4159.1981.tb00594.x Evenden, 1998, The pharmacology of impulsive behavior in rats IV, Psychopharmacology (Berl.), 140, 319, 10.1007/s002130050773 Evenden, 1999, Impulsivity, J. Psychopharmacol., 13, 180, 10.1177/026988119901300211 Evenden, 1999, The pharmacology of impulsive behavior in rats VI, Psychopharmacology (Berl.), 146, 413, 10.1007/PL00005486 Fibiger, 1977, An anatomical and electrophysiological investigation of the serotonergic projection from dorsal raphe nucleus to substantia nigra in the rat, Neuroscience, 2, 975, 10.1016/0306-4522(77)90120-8 Gudelsky, 1994, Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonist, Eur. J. Pharmacol., 264, 325, 10.1016/0014-2999(94)90669-6 Hall, 1988, Raclopride, a new selective ligand for the dopamine-D2 receptors, Prog. Neuropsychopharmacol. Biol. Psychiatry, 12, 559, 10.1016/0278-5846(88)90001-2 Harrison, 1997, Double dissociable effects of median- and dorsal-raphé lesions on the performance of the five-choice serial reaction time test of attention in rats, Behav. Brain Res., 89, 135, 10.1016/S0166-4328(97)00053-3 Harrison, 1997, Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance, Psychopharmacology (Berl.), 133, 329, 10.1007/s002130050410 Heidbreder, 1998, Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens, Synapse, 29, 310, 10.1002/(SICI)1098-2396(199808)29:4<310::AID-SYN3>3.0.CO;2-8 Herve, D.; Pickel, V. M.; Joh, T. H.; Beaudet, A. Serotonin axon terminals in the ventral tegmental area of the rat: Fine structure and synaptic input to dopaminergic neurons. Brain Res. 435:71–83; 1987. Ho, M. Y.; Al Zahrani, S. S.; Al Ruwaitea, A. S.; Bradshaw, C. M.; Szabadi, E. 5-hydroxytryptamine and impulse control: Prospects for behavioral analysis. J. Psychopharmacol. 12:68–78; 1998. Jentsch, 1999, Impulsivity resulting from frontostriatal dysfunction in drug abuse, Psychopharmacology (Berl.), 146, 373, 10.1007/PL00005483 Kelland, 1990, Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons, J. Pharmacol. Exp. Ther., 253, 803 Kelley, 1997, Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core, Proc. Natl. Acad. Sci. USA, 94, 12174, 10.1073/pnas.94.22.12174 Koskinen, T.; Puumala, T.; Ruotsalainen, S.; Lappalainen, R.; Männistö, P.; Koivisto, E.; Sirviö, J. The role of 5-HT2A receptors in the modulation of attention and response control in rats. J. Psychopharmacol. 11(Suppl.):A65; 1997. Koskinen, 2000, Activation of 5-HT2A receptors impairs response control of rats in a 5-CSRT task, Neuropharmacology, 39, 471, 10.1016/S0028-3908(99)00159-8 Koskinen, 2000, The 5-HT2 receptor activation enhances impulsive responding without increasing motor activity in rats, Pharmacol. Biochem. Behav., 66, 729, 10.1016/S0091-3057(00)00241-0 Koob, 1998, Drug abuse, Science, 278, 52, 10.1126/science.278.5335.52 Leysen, 1993, Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects, Psychopharmacology (Berl.), 112, S40, 10.1007/BF02245006 Linnoila, M.; Virkkunen, M.; Scheinin, M.; Nuutila, A.; Rimon, R.; Goodwin, F. K. Low cerebrospinal fluid 5-hydroxyindolacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 33:2609–2614; 1983. López-Gimenés, 1997, Selective visualisation of rat brain 5-HT2A receptors by autoradiography with (3H)MDL 100907, Naunyn Schmeidebergs Arch. Pharmacol., 356, 446, 10.1007/PL00005075 Maldonado-Irizarry, 1995, Excitotoxic lesions of the core and shell subregions of the nucleus accumbens differentially disrupt body weight regulation and motor activity in rat, Brain Res. Bull., 38, 551, 10.1016/0361-9230(95)02030-2 Marcus, 1996, Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens, Eur. Neuropsychopharmacol., 6, 29, 10.1016/0924-977X(95)00056-U McQuade, R. D.; Ford, D.; Duffy, R. A.; Chipkin, R. E.; Iorio, L. C.; Barnett, A. Serotonergic component of SCH23390: In vitro and in vivo binding analyses. Life Sci. 43:1861–1869; 1988. Meltzer, 1989, Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKI values, J. Pharmacol. Exp. Ther., 251, 238 Meltzer, 1991, Effects of antipsychotic drugs on serotonin receptors, Pharmacol. Rev., 43, 587 Meyer, M. E.; Cottrell, G. A.; Van Hartesveldt, C. Dopamine D1 antagonists potentiate the duration of bar and cling catalepsy and dorsal immobility response in rats. Pharmacol. Biochem. Behav. 41:507–510; 1992. Meyer, M. E.; Cottrell, G. A.; Van Hartesveldt, C.; Potter, T. J. Effects of dopamine D1 antagonists SCH23390 and SK&F83566 on locomotor activities in rats. Pharmacol. Biochem. Behav. 44:429–432; 1993. Muir, 1996, The cerebral cortex of the rat and visual attentional function, Cereb. Cortex, 6, 470, 10.1093/cercor/6.3.470 Muir, 1995, Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron, Psychopharmacology (Berl.), 118, 82, 10.1007/BF02245253 Ng, 1999, Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors, J. Neurosci. Res., 55, 600, 10.1002/(SICI)1097-4547(19990301)55:5<600::AID-JNR7>3.0.CO;2-# Nomikos, 1996, The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum, J. Neural. Transm. Gen. Sect., 103, 541, 10.1007/BF01273152 Palfreyman, 1993, Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function, Psychopharmacology (Berl.), 112, S60, 10.1007/BF02245008 Parkinson, 1999, Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by d-amphetamine, J. Neurosci., 19, 2401, 10.1523/JNEUROSCI.19-06-02401.1999 Pazos, A.; Cortes, R.; Palacios, J. M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346:231–249; 1985. Pazos, 1987, Serotonin receptors in the human brain-IV. Autoradiographic mapping of serotonin-2 receptors, Neuroscience, 21, 123, 10.1016/0306-4522(87)90327-7 Phillips, 1991, Time-dependent, schedule-dependent, and reinforcer-dependent effects of pimozide and amphetamine, Psychopharmacology (Berl.), 104, 125, 10.1007/BF02244566 Plaznik, 1994, Antidepressant treatment and limbic serotonergic mechanisms regulating rat locomotor activity, Pharmacol. Biochem. Behav., 48, 315, 10.1016/0091-3057(94)90533-9 Puumala, 1998, Changes in activities of dopamine and serotonin system in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task, Neuroscience, 83, 489, 10.1016/S0306-4522(97)00392-8 Robbins, 1992, Functions of dopamine in the dorsal and ventral striatum, Semin. Neurosci., 4, 119, 10.1016/1044-5765(92)90010-Y Robbins, 1996, Neurobehavioral mechanisms of reward and motivation, Curr. Opin. Neurobiol., 6, 228, 10.1016/S0959-4388(96)80077-8 Robbins, 1998, Neural systems underlying arousal and attention, Ann. N. Y. Acad. Sci., 846, 222, 10.1111/j.1749-6632.1998.tb09740.x Ruotsalainen, 2000, Blockade of muscarinic, rather than nicotinic, receptors impairs attention, but does not interact with serotonin depletion, Psychopharmacology (Berl.), 148, 111, 10.1007/s002130050032 Ruotsalainen, 1997, Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks, Eur. Neuropsychopharmacol., 7, 99, 10.1016/S0924-977X(96)00389-6 Schultz, 1992, Neuronal activity in monkey ventral striatum related to the expectation of reward, J. Neurosci., 12, 4595, 10.1523/JNEUROSCI.12-12-04595.1992 Seeman, P.; Van Tol, H. H. M. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15:264–270; 1994. Smith, 2000, Differential effects of dopamine receptor subtype blockade on performance of rats in a reaction-time paradigm, Psychopharmacology (Berl.), 148, 355, 10.1007/s002130050063 Soubrié, 1986, Reconciling the role of central serotonin neurones in human and animal behavior, Behav. Brain Sci., 9, 319, 10.1017/S0140525X00022871 Soubrié, 1984, Functional aspects of serotonin transmission in the basal ganglia, Neuroscience, 13, 605, 10.1016/0306-4522(84)90082-4 Ugedo, 1989, Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition, Psychopharmacology (Berl.), 98, 45, 10.1007/BF00442004 Van Bockstaele, E. J.; Biswas, A.; Pickel, V. M. Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to rat prefrontal cortex and nucleus accumbens. Brain Res. 624:188–198; 1993. Voorn, 1989, Compartmental organization of the ventral striatum of the rat, J. Comp. Neurol., 289, 189, 10.1002/cne.902890202 Voorn, 1994, Evidence for two neurochemical divisions in the human nucleus accumbens, Eur. J. Neurosci., 6, 1913, 10.1111/j.1460-9568.1994.tb00582.x Wadenberg, 1995, Antagonism by the 5-HT2A/C receptor agonist DOI of raclopride-induced catalepsy in the rat, Eur. J. Pharmacol., 294, 247, 10.1016/0014-2999(95)00535-8 Westfall, 1982, Inhibition of the electrically induced release of [3H]dopamine by serotonin from superfused rat striatal slices, Neurosci. Lett., 28, 205, 10.1016/0304-3940(82)90153-7 Williams, 1993, Neuronal responses in the ventral striatum of the behaving macaque, Behav. Brain Res., 55, 243, 10.1016/0166-4328(93)90120-F Yan, 2000, Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission, Brain Res. Bull., 51, 75, 10.1016/S0361-9230(99)00208-7